Advertisement
Canada markets open in 5 hours 49 minutes

  • S&P/TSX

    21,871.96
    +64.59 (+0.30%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • CAD/USD

    0.7300
    -0.0001 (-0.01%)
     

  • CRUDE OIL

    82.17
    +0.27 (+0.33%)
     

  • Bitcoin CAD

    90,624.38
    +74.22 (+0.08%)
     

  • CMC Crypto 200

    1,397.44
    -17.32 (-1.22%)
     

  • GOLD FUTURES

    2,321.10
    -25.30 (-1.08%)
     

  • RUSSELL 2000

    1,967.47
    +19.82 (+1.02%)
     

  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     

  • NASDAQ futures

    17,363.50
    +13.50 (+0.08%)
     

  • VOLATILITY

    16.69
    -0.25 (-1.48%)
     

  • FTSE

    8,069.14
    +45.27 (+0.56%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • CAD/EUR

    0.6831
    -0.0019 (-0.28%)
     

Agile Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on Thursday, August 11, 2022

Agile Therapeutics, Inc.
·2 min read
Agile Therapeutics, Inc.
Agile Therapeutics, Inc.

Live Conference Call and Webcast at 4:30 p.m. ET

PRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report second quarter 2022 financial results after the market close on Thursday, August 11, 2022. Following the release, the Company will host a live conference call and webcast at 4:30 p.m. ET to discuss the Company’s financial results and provide a business update.

Date

Thursday, August 11, 2022

Time

4:30 p.m. ET

Webcast (live and archived)

Events & Presentations

Dial-in numbers

(888) 330-2454 (U.S. toll-free) or (240) 789-2714

Conference ID

7871426

Investors interested in listening to the conference call may do so by dialing (888) 330-2454 for domestic callers or (240) 789-2714 for international callers. The Conference ID is 7871426. A live webcast will be available in the Events and Presentations section of the Investor Relations page at https://ir.agiletherapeutics.com/events-and-presentations/, or by clicking here.

ADVERTISEMENT

Please log in approximately 10 minutes prior to the scheduled start time. The archived webcast will be available in the Events and Presentations section of the company's website.

About Agile Therapeutics, Inc.
Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.

CONTACT: Contact:  Matt Riley Head of Investor Relations & Corporate Communications mriley@agiletherapeutics.com